CNRS Nantes University US2B US2B
home |  start a new run |  job status |  references&downloads |  examples |  help  

Should you encounter any unexpected behaviour,
please let us know.
 elNémo has been hacked on november 27th.
It has been moved away and runs again.
**Still some additional cleaning from time to time**
Sorry for the inconvenience.


***  IMMUNE SYSTEM 14-NOV-18 6N2U  ***

<R2> analysis for 2604131021151763097

---  normal mode 66  ---

This page gives a visualization of the normalized mean square displacement <R2> of all C-alpha atoms in the protein that are associated to this mode (black bars). The three components of the corresponding eigenvector are shown on the left (colored bars). Here is the raw data for <R2> and for the eigenvector (shift-click on the links for download).

XYZresidue<R2><R2>max = 0.0776
LYS 10.0183
GLU 20.0143
LEU 30.0109
ARG 40.0201
CYS 50.0265
GLN 60.0138
CYS 70.0332
ILE 80.0455
LYS 90.0231
THR 100.0113
TYR 110.0148
SER 120.0291
LYS 130.0583
PRO 140.0274
PHE 150.0095
HIS 160.0119
PRO 170.0086
LYS 180.0092
PHE 190.0062
ILE 200.0069
LYS 210.0104
GLU 220.0374
LEU 230.0234
ARG 240.0163
VAL 250.0222
ILE 260.0138
GLU 270.0156
SER 280.0218
GLY 290.0361
PRO 300.0211
HIS 310.0062
CYS 320.0231
ALA 330.0229
ASN 340.0512
THR 350.0080
GLU 360.0083
ILE 370.0264
ILE 380.0253
VAL 390.0143
LYS 400.0084
LEU 410.0125
SER 420.0167
ASP 430.0298
GLY 440.0183
ARG 450.0310
GLU 460.0335
LEU 470.0295
CYS 480.0289
LEU 490.0194
ASP 500.0190
PRO 510.0330
LYS 520.0197
GLU 530.0059
ASN 540.0166
TRP 550.0125
VAL 560.0089
GLN 570.0121
ARG 580.0087
VAL 590.0057
VAL 600.0100
GLU 610.0104
LYS 620.0060
PHE 630.0112
LEU 640.0149
LYS 650.0098
ARG 660.0071
ALA 670.0209
GLU 680.0698
ASN 690.0776

If you find results from this site helpful for your research, please cite one of our papers:

elNémo is maintained by Yves-Henri Sanejouand.
It was developed by Karsten Suhre.
Between 2003 and 2014, it was hosted by IGS (Marseille).
Between 2015 and 2025, it was hosted by US2B (Nantes).
Last modification: december 26th, 2025.